Clinical Guidelines > Current Guidelines >

BHIVA guidelines for the management of tuberculosis in adults living with HIV


The overall purpose of these guidelines is to help physicians manage adults with tuberculosis (TB)/human immunodeficiency virus (HIV) co-infection. Recommendations for the treatment of TB in HIV-positive adults are similar to those in HIV-negative adults. Of note, the term ‘HIV’ refers to HIV-1 throughout these guidelines.


British HIV Association guidelines for the management of tuberculosis in adults living with HIV 2018 NHS Evidence accredited provider

Additional information

Literature search strategies

Public consultation comments

The comments received during the public consultation can be found below. All comments were reviewed and discussed and the guidelines amended where appropriate.

Download the comments received by the BHIVA Secretariat during the web consultation process

Declaration of interests

Download the declaration of interests from writing group members

Writing group members

  • Margherita Bracchi, Chelsea and Westminster Hospital, NHS Foundation Trust

  • Clare van Halsema, North Manchester General Hospital, Liverpool School of Tropical Medicine

  • Frank Post, King's College Hospital NHS Foundation Trust

  • Funmi Awosusi, Barts Health NHS Trust, HIVPA

  • Alison Barbour, Croydon Health Services NHS Trust

  • Steve Bradley, UK Community Advisory Board

  • Katherine Coyne, Homerton University Hospital

  • Esther Dixon-Williams, UK Community Advisory Board

  • Andrew Freedman, Cardiff University School of Medicine

  • Pauline Jelliman, Royal Liverpool and Broadgreen University Hospital Trust, NHIVNA

  • Saye Khoo, University of Liverpool

  • Clifford Leen, NHS Lothian

  • Marc Lipman, Royal Free London NHS Foundation Trust

  • Sebastian Lucas, Guy's and St Thomas' Hospital NHS Foundation Trust

  • Rob Miller, Mortimer Market Centre

  • Kay Seden, University of Liverpool

  • Anton Pozniak (Chair), Chelsea and Westminster Hospital NHS Foundation Trust

Guidelines updates and date of next review

We aim to revise these guidelines in 2021. In the meantime, the writing group will confer at least annually to consider new information from high-quality studies and will issue revisions or updates should clinically important and relevant data become available.